IL27 and atherosclerosis: Compared with the mice treated with PBS, the mice treated with IL-27 during the progression of atherosclerosis displayed a reduction of 24.4% in aortic sinus atherosclerotic lesion size (605.7 ± 38 × 103 μm2 vs 457.8 ± 37 × 103 μm2, respectively; P = 0.02; Figure 2).